Showing results (1081-1090 of 6,669) with videos related to

Sort By:
Pageof 667
Annals of Hematology|April 6, 2020
Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myelomaTadao Ishida, Hideo Kimura, Shuji Ozaki, et al.
Annals of Hematology|January 25, 2020
Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, AlgeriaMalek Benakli, Redhouane Ahmed Nacer, Farih Mehdid, et al.
Annals of Hematology|April 3, 2020
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myelomaEvangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, et al.
Annals of Hematology|September 25, 2020
Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia AAlexander Solms, Anita Shah, Erik Berntorp, et al.
Annals of Hematology|September 19, 2020
Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantationBeatrice Drexler, Felicitas Zurbriggen, Tamara Diesch, et al.
Annals of Hematology|September 15, 2020
Genetic research and clinical analysis of deletional Chinese Gγ+(Aγδβ)0 -thalassemia and Southeast Asian HPFH in South ChinaYuanjun Wu, Qianyu Yao, Ming Zhong, et al.
Annals of Hematology|September 29, 2020
Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09)Sora Kang, Hyungwoo Cho, Byeong Seok Sohn, et al.
Annals of Hematology|January 4, 2021
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myelomaStefania Oliva, Lorenzo De Paoli, Marina Ruggeri, et al.
Annals of Hematology|January 3, 2021
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinibGiovanni Caocci, Olga Mulas, Isabella Capodanno, et al.
Annals of Hematology|January 5, 2021
Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapyHenu Kumar Verma, Yashwant Kumar Ratre, L V K S Bhaskar, et al.
Pageof 667